Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share
VANCOUVER, Wash., Dec. 26, 2023 (GLOBE NEWSWIRE) — Riverview Bancorp, Inc. (Nasdaq GSM: RVSB) (“Riverview” or the “Company”) today announced […]
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
DALLAS, Dec. 26, 2023 (GLOBE NEWSWIRE) — On December 26, 2023, Hallmark Financial Services, Inc. provided notice to the Nasdaq […]
Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
ELYXYB® is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or […]
Red Cat Endorses Passing of the American Security Drone Act
SAN JUAN, Puerto Rico, Dec. 26, 2023 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), […]
VERB’s MARKET.live Adds Twenty More Retailers to Its Livestream Social Shopping Platform
LOS ALAMITOS, Calif. and LAS VEGAS, Dec. 26, 2023 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or […]
Sunrise New Energy Announces Breakthrough Achievement in Sodium-ion Battery Hard Carbon Composite Material with Approval of Invention Patent by National Intellectual Property Office
ZIBO, China, Dec. 26, 2023 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: […]
DayDayCook Announces Agreement to Acquire Leading American Ready-to-Eat Thai Food Brand Yai’s Thai
NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) — DDC Enterprise, Ltd., (NYSEAM: DDC) (“DayDayCook,” “DDC,” or the “Company”), a leading […]
Mullen Delivers 63 More Class 3 Vehicles to Randy Marion Automotive Group Valued at $3,969,000; To-Date, 121 Class 3s Delivered Valued at $7,623,000
To date, Mullen has delivered 121 Class 3vehicles for a total of $7,623,000 invoiced. Company focused and on track to […]
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (“Atreca”) (NASDAQ: BCEL), a biotechnology company focused on developing novel […]
CVRx receives FDA approval for expanded labeling of Barostim
MINNEAPOLIS, Dec. 26, 2023 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that […]
